Information Provided By: 
Fly News Breaks for August 23, 2016
MDRX
Aug 23, 2016 | 07:49 EDT
As previously reported, Leerink analyst David Larsen upgraded Allscripts to Outperform from Market Perform saying he believes that the company's core fundamentals are improving "significantly." The analyst expects adjusted EPS to grow by over 20% year over year in 2016 and 2017, and believes that Allscripts is becoming a more attractive acquisition candidate. Larsen also raised his price target on the shares to $17 from $16.
News For MDRX From the Last 2 Days
There are no results for your query MDRX
